Telix Pharmaceuticals Limited (TLPPF) Revenue 2023–2025
Telix Pharmaceuticals Limited (TLPPF) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$803.8MFY2025 · since FY2023: $333.0M → $803.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $803.8M | +55.6% |
| FY2024 | $516.6M | +55.1% |
| FY2023 | $333.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TLPPF financial trends
TLPPF Net incomeTLPPF Net marginTLPPF Gross profitTLPPF Gross marginTLPPF Operating incomeTLPPF Operating marginTLPPF Operating cash flowTLPPF Free cash flowTLPPF Capital expendituresTLPPF Return on equityTLPPF Stock buybacksTLPPF Dividends paidTLPPF Total assetsTLPPF Total liabilitiesTLPPF Shareholders’ equityTLPPF overview →